|
Butylhydroxybutylnitrosamine
|
D002085 |
[A substituted carcinogenic nitrosamine.
] |
|
Butylamines
|
D002082 |
[Isomeric amines of butane, where an amino group replaces a hydrogen on one of the four carbons. They include isobutylamine, n-Butylamine, sec-Butylamine, and tert-Butylamine.
] |
|
Butylated Hydroxyanisole
|
D002083 |
[Mixture of 2- and 3-tert-butyl-4-methoxyphenols that is used as an antioxidant in foods, cosmetics, and pharmaceuticals.
] |
|
Tylenchida
|
B01.050.500.500.294.400.984 |
|
|
Betrayal
|
F01.829.401.023 |
|
|
Hepatitis B Antibodies
|
D12.776.377.715.548.114.254.450.504 |
|
|
Natriuresis
|
G08.852.179.557 |
|
|
Diuresis
|
G08.852.179 |
|
|
Substance Abuse, Oral
|
C25.775.814 |
|
|
Gliclazide
|
D02.886.590.795.475 |
|
|
Immunologic Surveillance
|
G12.450.050.400.412 |
|
|
Immunity, Cellular
|
G12.450.050.400 |
|
|
Tetrapleura
|
B01.650.940.800.575.912.250.401.898 |
|
|
Dihydroergotamine
|
D03.132.327.412.225 |
|
|
Nitric Oxide Donors
|
D27.505.519.656 |
|
|
CD48 Antigen
|
D12.776.543.550.418.180 |
|
|
Hemoglobinuria, Paroxysmal
|
C15.378.071.141.560 |
|
|
HTLV-I Antibodies
|
D12.776.124.486.485.114.254.150.500 |
|
|
Deltaretrovirus Antibodies
|
D12.776.124.486.485.114.254.150 |
|
|
Hospitals, Municipal
|
N02.278.421.660.400 |
|
